Patients in Clinical Trials are Sub-Optimally Protected for Drug-Drug Interactions: A Call for Action. [PDF]
Burger D+6 more
europepmc +1 more source
Towards streamlined product information: reporting of transporter-mediated drug interactions. [PDF]
Asmar V+5 more
europepmc +1 more source
Knowledge of Food-Drug Interactions among Medical University Students. [PDF]
Jelińska M+5 more
europepmc +1 more source
High-performance PBPK model for predicting CYP3A4 induction-mediated drug interactions: a refined and validated approach. [PDF]
Yang CG+5 more
europepmc +1 more source
Treatment of Onychomycosis and the Drug-Drug Interactions in Patients with Diabetes Mellitus and Diabetic Foot Syndrome: A Systematic Review. [PDF]
Navarro-Pérez D+5 more
europepmc +1 more source
Predicting the toxic side effects of drug interactions using chemical structures and protein sequences. [PDF]
Zhang L, Sheng Y, Yang J, Hu Z, Peng B.
europepmc +1 more source
Exploring potential drug-drug interactions in discharge prescriptions: ChatGPT's effectiveness in assessing those interactions. [PDF]
Thapa RB, Karki S, Shrestha S.
europepmc +1 more source
Evaluation of Complex Drug Interactions Between Elexacaftor-Tezacaftor-Ivacaftor and Statins Using Physiologically Based Pharmacokinetic Modeling. [PDF]
Hong E, Chung PS, Rao AP, Beringer PM.
europepmc +1 more source
A Rare Case of Complete Atrioventricular Block Induced by Lithium Toxicity: Impact of Drug Interactions With Telmisartan. [PDF]
Chen CY, Chang BJ, Chiu NM.
europepmc +1 more source